MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202647070988 A) filed by Gilgamesh Pharmaceuticals, Inc. on June 08, 2026, for Methods Of Treating Psychiatric Disorders Or Pain Using (r)-2-(4-Fluorophenyl)-2- (methylamino)cyclohexan-1-One Or Pharmaceutically Acceptable Salts Thereof.
Inventors include Kruegel, Andrew Carry; Marek, Gerard Joseph; and Hughes, Zoe A..
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present disclosure relates to methods of treating a patient having a psychiatric disorder or pain comprising administering to the patient in need thereof a base compound or a pharmaceutically acceptable salt thereof as defined herein in specific dosing regimens.
Disclaimer: Curated by HT Syndication.